UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

Cancer treatment reviews, 2013-12, Vol.39 (8), p.839-850

2013

Link zum Volltext

Verfügbarkeit prüfen

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

Expert opinion on biological therapy, 2011-12, Vol.11 (12), p.1663-1668

2011

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1553-1561

2007

Link zum Volltext

Verfügbarkeit prüfen

Taxane‐Platinum Combinations in Advanced Non‐Small Cell Lung Cancer: A Review

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (S2), p.16-23

Rigas, James R.

2004

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

The lancet oncology, 2016-07, Vol.17 (7), p.984-993

2016

Link zum Volltext

Verfügbarkeit prüfen

Current Treatment Paradigms for Locally Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2007-06, Vol.2 (6), p.S77-S85

2007

Link zum Volltext

Verfügbarkeit prüfen

Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models

Cancer prevention research (Philadelphia, Pa.), 2011-06, Vol.4 (6), p.818-828

2011

Link zum Volltext

Verfügbarkeit prüfen

A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer

Clinical cancer research, 2007-03, Vol.13 (6), p.1794-1800

2007

Link zum Volltext

Verfügbarkeit prüfen

Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors

Journal of proteomics, 2013-10, Vol.91, p.286-296

2013

Link zum Volltext

Verfügbarkeit prüfen

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Cancer management and research, 2019-01, Vol.11, p.9469-9481

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

Clinical cancer research, 2004-11, Vol.10 (22), p.7547-7554

2004

Link zum Volltext

Verfügbarkeit prüfen

Trimodality Therapy for Stage II–III Carcinoma of the Esophagus: A Dose-Ranging Study of Concurrent Capecitabine, Docetaxel, and Thoracic Radiotherapy

Journal of thoracic oncology, 2013-04, Vol.8 (4), p.487-494

2013

Link zum Volltext

Verfügbarkeit prüfen

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: A retrospective review of 50 cases

Diagnostic cytopathology, 2013-01, Vol.41 (1), p.15-21

2013

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer in a U.S. Population with Low to Moderate Arsenic Exposure

Environmental health perspectives, 2009-11, Vol.117 (11), p.1718-1723

2009

Link zum Volltext

Verfügbarkeit prüfen

Bexarotene and Erlotinib for Aerodigestive Tract Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8757-8764

2005

Link zum Volltext

Verfügbarkeit prüfen

α-1-Acid Glycoprotein As an Independent Predictor for Treatment Effects and a Prognostic Factor of Survival in Patients with Non-small Cell Lung Cancer Treated with Docetaxel

Clinical cancer research, 2003-03, Vol.9 (3), p.1077-1082

2003

Link zum Volltext

Verfügbarkeit prüfen

The Retinoids and Cancer Prevention Mechanisms

The oncologist (Dayton, Ohio), 2000-10, Vol.5 (5), p.361-368

2000

Link zum Volltext

Verfügbarkeit prüfen

Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2001-05, Vol.19 (10), p.2626-2637

2001

Link zum Volltext

Verfügbarkeit prüfen

ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer

Future oncology (London, England), 2019-09, Vol.15 (26), p.3003

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Clinical cancer research, 2010-03, Vol.16 (6), p.1938-1949

2010

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant vinorelbine and cisplatin in elderly patients : National cancer institute of Canada and intergroup study JBR. 10

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1553-1561

2007

Link zum Volltext

Verfügbarkeit prüfen

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Clinical and applied thrombosis/hemostasis, 2006-10, Vol.12 (4), p.389-396

2006

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

Cancer, 2015-12, Vol.121 (23), p.4165-4172

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-01, Vol.6 (1), p.139-147

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(119)

Sprache

Englisch
(119)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(72)
Science & Technology
(67)
Life Sciences & Biomedicine
(65)
Oncology
(46)
Female
(42)
Male
(42)
Middle Aged
(37)
Aged
(36)
Biological And Medical Sciences
(36)
Lung Neoplasms - Drug Therapy
(36)
Medical Sciences
(36)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(34)
Chemotherapy
(29)
Adult
(28)
Pharmacology. Drug Treatments
(24)
Antineoplastic Agents
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Lung Neoplasms - Pathology
(17)
Non-Small Cell Lung Cancer
(16)
Carcinoma, Non-Small-Cell Lung - Pathology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dabrafenib plus trametinib in patients with previously treated BRAFV600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10

Taxane‐Platinum Combinations in Advanced Non‐Small Cell Lung Cancer: A Review

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

Current Treatment Paradigms for Locally Advanced Non-small Cell Lung Cancer

Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models

A Proof-of-Principle Clinical Trial of Bexarotene in Patients with Non–Small Cell Lung Cancer

Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract Cancers

Trimodality Therapy for Stage II–III Carcinoma of the Esophagus: A Dose-Ranging Study of Concurrent Capecitabine, Docetaxel, and Thoracic Radiotherapy

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: A retrospective review of 50 cases

Lung Cancer in a U.S. Population with Low to Moderate Arsenic Exposure

Bexarotene and Erlotinib for Aerodigestive Tract Cancer

α-1-Acid Glycoprotein As an Independent Predictor for Treatment Effects and a Prognostic Factor of Survival in Patients with Non-small Cell Lung Cancer Treated with Docetaxel

The Retinoids and Cancer Prevention Mechanisms

Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non–Small-Cell Lung Cancer

ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Adjuvant vinorelbine and cisplatin in elderly patients : National cancer institute of Canada and intergroup study JBR. 10

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer

Suchergebnisse filtern